GLP-1s and muscle loss — why resistance training is non-negotiable
Most people on GLP-1s are losing weight. Many are also losing muscle. The STEP trials did not require resistance training. That omission may be their most important limitation.
GLP-1s and energy — when does it actually get easier to move?
Fatigue is commonly reported in the first months. Understanding the mechanism — and the timeline — helps patients build realistic expectations for when exercise becomes sustainable.
What the STEP trials said about exercise — and what they failed to measure
The landmark semaglutide trials included “lifestyle counselling” as a standard component. What that actually meant — and what structured exercise would have added — is a story the trials cannot tell.